The European Medicines Agency (EMA), after initial rejection based on an unfavourable risk-benefit balance, recently recommended approval of lecanemab for treating people with mild cognitive ...

A group of expert neurologists have expressed concerns at the European Commission’s (EC) decision to formally approve the Alzheimer’s drug lecanemab (Leqembi) despite uncertain benefits. Lecanemab, ...

Short term trials with surrogate measures instead of hard outcomes are often used to study chronic diseases. The effects of an intervention may, however, take time to develop and persist after ...

Improving people’s experiences during and between care episodes and reducing the fear and harm associated with long waits can restore public satisfaction in the NHS, writes Chris Graham Since the ...

Huaiyu Tian and colleagues argue that to improve sustainable malaria control and reduce the risk of disease resurgence, targeted interventions can be optimised for eliminating malaria in areas ...

Qiyong Liu and colleagues consider the experience of basic malaria elimination, resurgence, and re-elimination in the Huai River Basin in central China, as well as lessons learnt to help to inform ...

Harvard University has defied demands from US president Donald Trump for control over academic decision making and instead sued his administration, charging it with violating the university’s ...

Qiyong Liu and colleagues revisit the strategies and measures adopted in China to control and eliminate malaria and discuss what can be learnt from its elimination Malaria is a mosquito-borne ...

As the final draft of the 32 page pandemic accord1 lit up the giant screen at the World Health Organization’s (WHO) Geneva headquarters at 3 am on 16 April, the world’s health ministers and diplomats ...

GP Bryony Kendall talks to Helen Jones about her role on NICE women’s and reproductive health guidelines committee “I always wanted to be a doctor, and it’s such a privilege and a joy to be a GP and ...

Sixty years ago cystic fibrosis was practically a death sentence, but the remarkable progress of science and medicine means that people with the condition can live into their 60s. What new health ...

The country’s success is a call to action for other affected areas China, burdened with an estimated 30 million malaria cases annually in the 1940s, reached a historic milestone when the World Health ...